Biotech Updates

Dow AgroSciences and Sangamo BioSciences Meet Agric Milestones

June 22, 2007

Dow AgroSciences and Sangamo BioSciences have successfully met their research milestones in their collaborative Research and Commercial License Agreement. They were able to apply Sangamo’s zinc finger DNA-binding protein technology to the generation of specific traits in maize and canola.

The technology has enabled the precise placement of a gene of interest into a specific native gene in maize. Philip Gregory, Sangamo’s vice president of research, said that this development has a “potentially significant impact on the cost and timelines of generating crop products with new and improved traits”. In addition, Sangamo’s technology holds the promise to enable gene editing of native traits and regulation of genes to influence metabolic profiles of plants.

Read the full release at: http://www.dowagro.com/newsroom/corporatenews/2007/20070619a.htm